Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study.
Abstract
BACKGROUND: The effectiveness of extracorporeal shock wave therapy in the treatment of plantar fasciitis is controversial. The objective of the present study was to test whether focused extracorporeal shock wave therapy is effective in relieving chronic heel pain diagnosed as plantar fasciitis.
METHODS: Two hundred and fifty subjects were enrolled in a prospective, multicenter, double-blind, randomized, and placebo-controlled U.S. Food and Drug Administration trial. Subjects were randomized to focused extracorporeal shock wave therapy (0.25 mJ/mm(2)) or placebo intervention, with three sessions of 2000 impulses in weekly intervals. Primary outcomes were both the percentage change of heel pain on the visual analog scale composite score (pain during first steps in the morning, pain with daily activities, and pain with a force meter) and the Roles and Maudsley score at twelve weeks after the last intervention compared with the scores at baseline.
RESULTS: Two hundred and forty-six patients (98.4%) were available for intention-to-treat analysis at the twelve-week follow-up. With regard to the first primary end point, the visual analog scale composite score, there was a significant difference (p = 0.0027, one-sided) in the reduction of heel pain in the extracorporeal shock wave therapy group (69.2%) compared with the placebo therapy group (34.5%). Extracorporeal shock wave therapy was also significantly superior to the placebo therapy for the Roles and Maudsley score (p = 0.0006, one-sided). Temporary pain and swelling during and after treatment were the only device-related adverse events observed.
CONCLUSIONS: The results of the present study provide proof of the clinically relevant effect size of focused extracorporeal shock wave therapy without local anesthesia in the treatment of recalcitrant plantar fasciitis, with success rates between 50% and 65%.
LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
Research topics
Related publications
View all publications- Saxena A, Fournier M, Gerdesmeyer L, Gollwitzer H.Muscles Ligaments Tendons J. 2(4):312-6. Print 2012 Oct.2013 Jan 21
- Publication
Fifth metatarsal fractures.
Berlet GC, Olms K, Saxena A.Foot Ankle Spec. 7(2):127-34. doi: 10.1177/1938640014524399. Epub 2014 Feb 26.2014 Apr 01 - Saxena A, Valerio DL, Behan SA, Hofer D.J Foot Ankle Surg. pii: S1067-2516(18)30285-0. doi: 10.1053/j.jfas.2018.07.009. [Epub ahead of print]2018 Dec 12
- Publication
In reference to: Endoscopic transcanal removal of symptomatic external auditory canal exostoses.
Hetzler D.Am J Otolaryngol. 36(6):843-4. doi: 10.1016/j.amjoto.2015.06.006. Epub 2015 Jul 9.2015 Nov 01 - Drieling RL, Ma J, Thiyagarajan S, Stafford RS.J Women's Health (Larchmt). 20(12):1895-907. doi: 10.1089/jwh.2010.2515. Epub 2011 Oct 4.2011 Dec 01




